Anti-stroke blood thinner shows promise in large clinical trials

Links shared publicly online about this topic.

722
total visits

Anti-stroke blood thinner shows promise in large clinical trials

In new and extensive clinical trials an experimental blood thinner called rivaroxaban is at least as good at preventing strokes as the drug warfarin -- that has been the most widely used agent for the past five decades in people with erratic heartbeats called atrial fibrillations. Researchers said this Monday that this drug also sharply reduces the risk of major bleeding that is seen with warfarin.

View full resource at news-medical.net

Tags: Stroke, Thrombotic Event, Clinical Trial, Anti-Clotting Medication, Xarelto, News, Preventing